The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of intraperitoneal fast-manufactured IL-9-secreting CEACAM5-targeted CAR-T cells in advanced colorectal cancer with peritoneal metastases.
 
Hangyu Zhang
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Yang Gao
No Relationships to Disclose
 
Yingzi Zhang
No Relationships to Disclose
 
Xudong Zhu
No Relationships to Disclose
 
Linling Wang
No Relationships to Disclose
 
Lulu Liu
No Relationships to Disclose
 
Junjie Shen
No Relationships to Disclose
 
Xiaomeng Dai
No Relationships to Disclose
 
Wenyu Wang
No Relationships to Disclose
 
Huihui Wang
No Relationships to Disclose
 
Zhou Tong
No Relationships to Disclose
 
Yi Zheng
No Relationships to Disclose
 
Peng Zhao
No Relationships to Disclose
 
Zhi Yang
Employment - Chongqing Precision Biotech Co., Ltd.
Leadership - Chongqing Precision Biotech Co., Ltd.
Stock and Other Ownership Interests - Chongqing Precision Biotech Co., Ltd.
Honoraria - Chongqing Precision Biotech Co., Ltd.
Research Funding - Chongqing Precision Biotech Co., Ltd.
Patents, Royalties, Other Intellectual Property - The preparation method and application of Chimeric Antigen Receptor (CAR) targeting Carcinoembryonic Antigen (CEA) and the associated lentiviral vector
 
Weijia Fang
No Relationships to Disclose
 
Cheng Qian
No Relationships to Disclose
 
Xuanwen Bao
No Relationships to Disclose